KCNN4
protein-codingpotassium calcium-activated channel subfamily N member 4, the group of Potassium calcium-activated channels
Gene summary
The protein encoded by this gene is part of a potentially heterotetrameric voltage-independent potassium channel that is activated by intracellular calcium. Activation is followed by membrane hyperpolarization, which promotes calcium influx. The encoded protein may be part of the predominant calcium-activated potassium channel in T-lymphocytes. This gene is similar to other KCNN family potassium channel genes, but it differs enough to possibly be considered as part of a new subfamily. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~14.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0017910
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014737
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014737
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009061
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014737
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Individuals have been described with severe anemia, and interventions such as RBC transfusions, erythropoietin, and splenectomy may be indicated
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KCNN4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002250.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 26 | 2 | 32 | ||
| missense | 2 | 2 | 98 | 9 | 111 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 4 | 4 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 3 | |||
| Total | 2 | 2 | 110 | 36 | 2 | 152 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002241.1 | 8 | MANE Select | |
| Ensembl | ENSP00000496939.1 | 8 | MANE Select | |
| Ensembl | ENSP00000471900.1 | 4 | Standard | |
| Ensembl | ENSP00000472513.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Protein digestion and absorption - Homo sapiens (human)
- Salivary secretion - Homo sapiens (human)
- Insulin secretion - Homo sapiens (human)
- miR-targeted genes in leukocytes - TarBase
- miR-targeted genes in lymphocytes - TarBase
Biological Process
- immune system process
- potassium ion transport
- calcium ion transport
- cell volume homeostasis
- defense response
Molecular Function
- potassium channel activity
- protein binding
- calmodulin binding
- calcium-activated potassium channel activity
- small conductance calcium-activated potassium channel activity
Cellular Component
- plasma membrane
- voltage-gated potassium channel complex
- vesicle
- neuron projection
- neuronal cell body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262888
- Coding exons
- 8
- Length
- 14725
- Individuals with no LoFs
- 125494
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 251
- Defined
- 125747
- p
- 0.00101
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.62 | 194 | 269 | 0.721 | 0.0000159 | 2695 |
| Missense (PolyPhen) | 63 | 99.913 | 0.63055 | 1044 | ||
| Synonymous | 0.755 | 108 | 118 | 0.912 | 0.00000688 | 936 |
| Loss of Function | 1.53 | 13 | 20.5 | 0.634 | 0.00000111 | 202 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.010 | 0.010 | notable |
| Latino/Admixed American | 0.0013 | 0.0012 | notable |
| Ashkenazi Jewish | 0.00050 | 0.00050 | rare |
| East Asian | 0.00013 | 0.00011 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00024 | 0.00023 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00066 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Forms a voltage-independent potassium channel that is activated by intracellular calcium (PubMed:26148990). Activation is followed by membrane hyperpolarization which promotes calcium influx. Required for maximal calcium influx and proliferation during the reactivation of naive T-cells. The channel is blocked by clotrimazole and charybdotoxin but is insensitive to apamin (PubMed:17157250, PubMed:18796614). {ECO:0000269|PubMed:17157250, ECO:0000269|PubMed:18796614, ECO:0000269|PubMed:26148990}.;
- Disease
- DISEASE: Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689]: An autosomal dominant hemolytic anemia characterized by primary erythrocyte dehydration. Erythrocytes exhibit decreased total cation and potassium content that are not accompanied by a proportional net gain of sodium and water. Affected individuals typically manifest mild to moderate compensated hemolytic anemia, with an increased erythrocyte mean corpuscular hemoglobin concentration and a decreased osmotic fragility, both of which reflect cellular dehydration. Their red cells exhibit a panel of various shape abnormalities such as elliptocytes, hemighosts, schizocytes, and very rare stomatocytic cells. Complications such as splenomegaly and cholelithiasis, resulting from increased red cell trapping in the spleen and elevated bilirubin levels, respectively, may occur. {ECO:0000269|PubMed:26148990, ECO:0000269|PubMed:26178367, ECO:0000269|PubMed:26198474}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.152
- RVIS EVS
- -0.12
- RVIS percentile EVS
- 45.13
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.600
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |